A combinational therapy of egfr-car nk cells and oncolytic

HIGHLIGHTS

• who: Top from the Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio, USA have published the research: A combinational therapy of EGFR-CAR NK cells and oncolytic, in the Journal: (JOURNAL)
• what: The authors explored whether oHSV-1 alone could lyse and destroy breast cancer cells, which have the capability of trafficking into the brain to form metastatic brain tumors. The overall goal of cancer therapy is to achieve durable effects and ultimately find a cure with minimal toxicity. The study showed that EGFR-CAR NK-92 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.